Of interest, extracting SMYD2 expression values from the Oncomine cancer array database [42] revealed that SMYD2 levels in AML are lower than in Acute Lymphoblastic Leukemia (ALL) (Supplementary Figure 8). Here, SMYD2 is linked to acute lymphoblastic leukemia.